We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUZ icon
851
Suzano
SUZ
$10.1B
$567K 0.02%
60,735
-29,124
-32% -$265K
KEY icon
852
KeyCorp
KEY
$24.2B
$567K 0.02%
27,463
+1,622
+6% +$30.2K
ESS icon
853
Essex Property Trust
ESS
$18.9B
$566K 0.02%
2,162
+145
+7% +$37.5K
UDR icon
854
UDR
UDR
$12.8B
$564K 0.02%
15,385
+1,291
+9% +$45.9K
KHC icon
855
Kraft Heinz
KHC
$31.1B
$564K 0.02%
23,244
+16,185
+229% +$403K
MRCY icon
856
Mercury Systems
MRCY
$6.16B
$562K 0.02%
7,702
+5
+0.1% +$372
SNEX icon
857
StoneX
SNEX
$8.62B
$562K 0.02%
13,284
-41
-0.3% -$1.72K
XEL icon
858
Xcel Energy
XEL
$50.7B
$561K 0.02%
7,596
+238
+3% +$18.8K
ALB icon
859
Albemarle
ALB
$13.5B
$558K 0.02%
3,946
BAP icon
860
Credicorp
BAP
$30.8B
$558K 0.02%
1,944
-135
-6% -$35.7K
DOC icon
861
Healthpeak Properties
DOC
$15.4B
$557K 0.02%
34,632
-3,018
-8% -$53.2K
SXT icon
862
Sensient Technologies
SXT
$5.43B
$554K 0.02%
5,893
-65
-1% -$6.13K
OLED icon
863
Universal Display
OLED
$3.75B
$553K 0.02%
4,739
+3,322
+234% +$431K
MTH icon
864
Meritage Homes
MTH
$4.88B
$553K 0.02%
8,405
+1,551
+23% +$107K
TSCO icon
865
Tractor Supply
TSCO
$16.6B
$553K 0.02%
11,052
+42
+0.4% +$2.26K
UFPI icon
866
UFP Industries
UFPI
$5.03B
$553K 0.02%
6,070
+809
+15% +$74.1K
LDOS icon
867
Leidos
LDOS
$14.4B
$552K 0.02%
3,060
+20
+0.7% +$3.79K
HALO icon
868
Halozyme
HALO
$9.76B
$552K 0.02%
8,196
-309
-4% -$20.8K
WST icon
869
West Pharmaceutical
WST
$23.1B
$547K 0.02%
1,989
CORT icon
870
Corcept Therapeutics
CORT
$9.78B
$546K 0.02%
15,697
-210
-1% -$16.5K
VNO icon
871
Vornado Realty Trust
VNO
$7.51B
$546K 0.02%
16,405
-8,625
-34% -$315K
VIG icon
872
Vanguard Dividend Appreciation ETF
VIG
$111B
$546K 0.02%
2,484
+557
+29% +$122K
APG icon
873
APi Group
APG
$17.1B
$542K 0.02%
14,157
+13,190
+1,364% +$488K
DCOM icon
874
Dime Commercial Bancshares
DCOM
$1.77B
$541K 0.02%
17,978
-109
-0.6% -$3.15K
EFX icon
875
Equifax
EFX
$21B
$541K 0.02%
2,493
+31
+1% +$6.79K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.